Shanrong Biotechnology Corp.
Shanrong Biotechnology Corp.
Your view on SRBT
Overview
What the company does, where it operates, and who runs it.
About Shanrong Biotechnology Corp.
- Industry
- Shell Companies
- Sector
- Financial Services
- CEO
- Colonel Timothy D. Ringgold
- Headquarters
- 9350 Wilshire Boulevard, Beverly Hills, CA, US
- Industry
- Shell Companies
- Sector
- Financial Services
- CEO
- Colonel Timothy D. Ringgold
- Headquarters
- 9350 Wilshire Boulevard, Beverly Hills, CA, US
Shanrong Biotechnology Corp. operates as a project management and executive consulting company.
The company refurbishes and upgrades armored vehicles with digital communications, as well as provides spare parts and equipment for military and police forces; and offers onsite maintenance, maintenance training, operator training, and tactical training services.
It also conducts program management, business development, and strategic studies and analyses in the defense, homeland security, information technology, and telecommunications markets. The company was formerly known as Defense Solutions Holding, Inc. and changed its name to Shanrong Biotechnology Corp. in September 2017.
Shanrong Biotechnology Corp. is based in Beverly Hills, California.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Shanrong Biotechnology Corp., and the rating behind it. SRBT last traded at $0.04; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Shanrong Biotechnology Corp.. Starting points for Shanrong Biotechnology Corp.: EPS -$0.05, beta -0.04 — an Shell Companies name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Shanrong Biotechnology Corp.. Shanrong Biotechnology Corp. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Shanrong Biotechnology Corp.. Trailing twelve-month EPS for Shanrong Biotechnology Corp. stands at -$0.05. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Shanrong Biotechnology Corp.. Shanrong Biotechnology Corp. has reported as a listed company since 2018. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Shanrong Biotechnology Corp. valued side by side against its closest peers. Shanrong Biotechnology Corp. is measured against Shell Companies peers within the Financial Services sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Shanrong Biotechnology Corp., and how their positions are changing. At a $134,318 market value, institutional positions materially move Shanrong Biotechnology Corp.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Shanrong Biotechnology Corp. executives and directors. Shares of Shanrong Biotechnology Corp. have traded between $0.04 and $0.65 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Shanrong Biotechnology Corp.. Shanrong Biotechnology Corp. is a $134,318 Financial Services company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Shanrong Biotechnology Corp.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Shanrong Biotechnology Corp.. Coverage tracks Shanrong Biotechnology Corp. within Shell Companies (Financial Services). Press releases and market coverage, newest first.